基因格局和循环胺的治疗进化:关注乳腺癌的焦点
Jiaoyan Cao1,2,3, Xin Xu4, Tao Lu5
1Department of Pathology, Chongqing Health Center for Women and Children, Women and Children's Hospital of Chongqing Medical University, Chongqing, China.
遗传变异显著影响乳腺癌患者对环胺化疗的反应. 了解这些药物基因组因素可以个性化治疗并减少不良影响.
科学领域:
- 药物基因组学 药物基因组学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 环胺是乳腺癌的基石化疗.
- 它的有效性和毒性是由个人的遗传构成调节的.
- 宿主遗传变异影响药物代谢,排毒,DNA修复和运输.
研究的目的:
- 为了审查循环胺在乳腺癌中的药物基因组学景观.
- 为了确定影响环胺的关键基因和多态性.
- 分析与治疗反应和毒性的临床相关性.
主要方法:
- 综合文献综述. 这是一个全面的文献综述.
- 在新陈代谢,排毒,DNA修复和运输基因中识别遗传变异.
- 对药物反应和不良事件的临床数据的分析.
主要成果:
- 在CYP2B6和CYP3A5中的多态性影响循环胺的激活和暴露.
- 在GSTM1和GSTT1中,零变异与毒性增加有关.
- 像XRCC1和ERCC2这样的DNA修复基因变异会影响治疗结果.
结论:
- 环胺的药物基因组分析对乳腺癌管理至关重要.
- 特定的遗传变异预测药物的疗效和毒性.
- 个性化医疗方法可以优化环胺治疗.
更多相关视频
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
